Amarin Corporation PLC (AMRN) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Over the past 4 years, Amarin Corporation PLC has achieved a revenue compound annual growth rate (CAGR) of -21.9%, while earnings have grown at 46.2% CAGR.
Historical revenue and profitability trends for Amarin Corporation PLC
The chart above illustrates Amarin Corporation PLC's revenue trajectory over the past 4 years. The revenue pattern shows the challenges the company has faced in recent periods.
Annual percentage change in revenue and earnings
Growth rates provide insight into the momentum of Amarin Corporation PLC's business.
How efficiently Amarin Corporation PLC converts revenue into profit
Profit margins reveal how much of each dollar of revenue Amarin Corporation PLC retains at different stages:
Analyst estimates and forward-looking indicators
Wall Street analysts project Amarin Corporation PLC to continue growing earnings in the coming year. The consensus analyst rating is 2.3333 based on 3 analysts.
Based on our comprehensive analysis, Amarin Corporation PLC (AMRN) demonstrates declining growth characteristics.
This growth analysis provides a comprehensive view of Amarin Corporation PLC's historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.
See how Amarin Corporation PLC stacks up against similar companies
Explore growth analysis for top stocks
Related: AMRN Valuation, AMRN Dividend, AMRN Financial Health
Compare: AMRN vs AAPL, AMRN vs MSFT, AMRN vs GOOGL